Article

Using the GAD-7 Scale in Multiple Sclerosis Patients

Analyzing the validity of anxiety testing


 

References

The 7-item Generalized Anxiety Disorder Scale (GAD-7) is a reliable and valid measure of anxiety in patients with multiple sclerosis (MS), according to an analysis of the psychometric properties of the scale.

Researchers administered the GAD-7 to 513 patients, and randomly split the sample to conduct an exploratory and confirmatory factor analysis and found:

• The scale showed an acceptable internal consistency and was highly correlated with the Hospital Anxiety and Depression Scale–Anxiety.

• GAD-7 scores were higher in women and patients with secondary progressive MS.

• Higher GAD-7 scores were associated with more depressive symptoms.

Citation: Terrill AL, Hartoonian N, Beier M, Salem R, Alschuler K. The 7-item Generalized Anxiety Disorder Scale as a tool for measuring generalized anxiety in multiple sclerosis. Int J MS Care. 2015;17(2):49-56. doi: 10.7224/1537-2073.2014-008.

Recommended Reading

CMSC Guidelines: MRI Protocols in Multiple Sclerosis
ICYMI Multiple Sclerosis
Experimental MS Drug May Repair Nerve Damage
ICYMI Multiple Sclerosis
Can Coffee Reduce the Risk of MS?
ICYMI Multiple Sclerosis
What Happens When Patients With MS Stop Taking Their Medication?
ICYMI Multiple Sclerosis
Epilepsy Drug May Preserve Eyesight for Patients With MS
ICYMI Multiple Sclerosis
Tips for Coping With Multiple Sclerosis
ICYMI Multiple Sclerosis
Switch to Oral Fingolimod May Improve MS Outcomes
ICYMI Multiple Sclerosis
Conference News Update—Federation of American Societies for Experimental Biology
ICYMI Multiple Sclerosis
Can FLAIR MRI Show Treatment Efficacy?
ICYMI Multiple Sclerosis
Robert Fox, MD
ICYMI Multiple Sclerosis